Skip to main content
Log in

Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

To evaluate the reactogenicity and immunogenicity of aHaemophilus influenzae type b conjugate vaccine (HbOC) and of a tricomponent acellular pertussis vaccine (DTaP) when injected simultaneously into either contralateral arms or into contralateral thighs, 110 infants were enrolled to receive three doses of DTaP at 3, 4, and 5 months and two HbOC doses at 3 and 5 months of age. Administration of either of the two vaccines into arms was associated with significantly more local side effects than administration into thighs. There was no difference in geometric mean concentration (GMC) values for any of the four vaccine antigens between subjects who had been vaccinated into arms or thighs. After immunization, all children had protective antibody titers to diphtheria toxin. While post vaccination the mean anti-tetanus toxoid GMC was ≥ 1.25 IU/ml, there was no significant rise as compared to the GMC before vaccination. GMCs of antibodies against the various pertussis antigens were similar to those observed before with the same DTaP vaccine. The simultaneous administration of DTaP and HbOC was safe and immunogenic irrespective of the site of vaccine administration, but significantly more local reactions occurred when vaccines were injected into arms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Centers for Disease Control Progress toward elimination ofHaemophilus influenzae type b disease among infants and children. MMWR 44 (1995) 545–550.

    Google Scholar 

  2. Klug, B., Plesker, R., Bittner-Grünwald, P., Czapla, D., Eckert-Ziem, M., Schwanig, M., Hoffmann, A. Haemophilus influenzae Typ-b-Konjugatimpfstoffe. Monatsschr. Kinderheilkd. 142 (1994) 350–354.

    Google Scholar 

  3. von Kries, R., Windfuhr, A., Lucking, A., Helwig, H. PreventingHaemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 340 (1992) 592–594.

    Google Scholar 

  4. Peltola, H., Kilpi, T., Anttila, M. Rapid disappearance ofHaemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 344 (1994) 469.

    Google Scholar 

  5. Black, S. B., Shinefield, H. R., Fireman, B., Jiatt, R., Polen, M., Vittinghoff, E., andthe Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group Efficacy in infancy of oligosaccharide conjugateHaemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr. Infect. Dis. J. 10 (1991) 97–104.

    Google Scholar 

  6. NN Impfverhalten. Infektionsepidemiologische Forschung 4 (1995) 22.

    Google Scholar 

  7. Schmitt, H. J., Wirsing von König, C. H., Neiss, A., Bogaerts, H., Bock, H. L., Schulte-Wissermann, H., Gahr, M., Schult, R., Folkens, J.U., Rauh, W., Clemens, R. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275 (1996) 37–41.

    Google Scholar 

  8. Trollfors, B., Taranger, J., Lagergard, T., Lind, L., Sundh, V., Zackrisson, G., Lowe, C. U., Blackwelder, W. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333 (1995) 1045–1050.

    Google Scholar 

  9. Greco, D., Salmaso, S., Mastrantonio, P., Giuliano, M., Tozzi, A. E., Anemona, A., Ciofi Degli Atti, M. L., Giammanco, A., Panei, P., Blackwelder, W. C., Kelin, D. L., Wassilak, S., andthe Progetto Pertosse Working Group A controlled trial of two acellular vaccines and one whole cell vaccine against pertussis. N. Engl. J. Med. 334 (1996) 341–348.

    Google Scholar 

  10. Gustafsson, L., Hallander, H. O., Olin, P., Reizenstein, E., Storsaeter, J. A controlled trial of a two-component acellular, a five-component acellular and a whole cell pertussis vaccine. N. Engl. J. Med. 334 (1996) 349–355.

    Google Scholar 

  11. Deutsche Gesellschaft für Pädiatrische Infektiologie Schutzimpfungen. In: DGPI-Handbuch 1995, Futuramed Verlag, München 1995.

    Google Scholar 

  12. Barra, A., Schulz, D., Ancoutier, P., Preud'homme, J. R. Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA. J. Immunol. Meth. 115 (1988) 111–117.

    Google Scholar 

  13. Camargo, M. E., Silveira, L., Furuta, J. A., Oliveira, E. P. T., Germak, O. A. Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum. J. Clin. Microbiol. 20 (1984) 772–774.

    Google Scholar 

  14. Melville-Smith, M., Seagroatt, V., Watkins, J. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera. J. Biol. Stand. 11 (1983) 137–144.

    Google Scholar 

  15. Schmitt, H. J., Schuind, A., Knuf, M., Beutel, K., Schulte-Wissermann, H., Gahr, M., Schult, R., Folkens, J., Rauh, W., Bogaerts, H., Bock, H. L., Clemens, R. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J. Pediatr. 129 (1996) 695–701.

    Google Scholar 

  16. Schmitt, H. J., Beutel, K., Schuind, A., Knuf, M., Wagner, S., Müschenborn, S., Bogaerts, H., Bock, H. L., Clemens, R. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus and tricomponent acellular pertussis vaccine at 14–28 months of age. J. Pediatr. 130 (1997) 616–623.

    Google Scholar 

  17. Decker, M. D., Edwards, K. M., Steinhoff, M. C., Rennels, M. B., Pichichero, M. E., Englund, J. A., Anderson, E. L., Deloria, M. A., Reed, G. F. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 96 (1995) 557–566.

    Google Scholar 

  18. Rennels, M. B., Reed, G. F., Decker, M. D., Edwards, K. M., Pichichero, M. E., Deloria, M. A., Englund, J. A., Anderson, E. L., Steinhoff, M. C., Deforest, A., Meade, B. D. Simultaneous administration ofHaemophilus influenzae type b vaccine with acellular or whole cell pertussis vaccine: effects on reactogenicity and immune response to pertussis vaccines. Pediatrics 96 (1995) 576–579.

    Google Scholar 

  19. Schmitt, H. J., Müschenborn, S., Wagner, S., Knuf, M., Bock, H. L., Bogaerts, H., Clemens, C. Immunogenicity and reactogenicity of a bicomponent and a tricomponent acellular pertussis-diphtheria-tetanus (DTaP) vaccine in primary immunization and as second year booster: a double-blind, randomized trial. Internat. J. Infect. Dis. 1 (1996) 1–8.

    Google Scholar 

  20. Eskola, J., Ölander, R. M., Hovi, T., Litmanen, L., Peltola, S., Kaythy, H. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity ofHaemophilus influenzae type b conjugate vaccine. Lancet 348 (1996) 1688–1692.

    Google Scholar 

  21. ACIP Recommendations for use ofHaemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, andHaemophilus b vaccine. MMWR Recommendations and Reports 42 (1993) 1–12.

    Google Scholar 

  22. Edwards, K. M., Meade, B. D., Decker, M. D., Reed, G. F., Rennels, M. B., Steinhoff, M. C., Anderson, E. L., Englund, J. A., Pichichero, M. E., Deloria, M. A., Deforest, A. D. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96 (1995) 548–557.

    Google Scholar 

  23. Storsaeter, J., Blackwelder, W. C., Hallander, H. O. Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am. J. Dis. Child 146 (1992) 167–172.

    Google Scholar 

  24. Centers for Disease Control, Anonymous: Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR 34 (1985) 105–108.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmitt, H.J., Wirsing von König, C.H., Zepp, F. et al. Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants. Infection 25, 298–302 (1997). https://doi.org/10.1007/BF01720400

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01720400

Keywords

Navigation